Knudra Diagnostics

Basic Information

5201 S Green St., Ste. 140
Salt Lake City, UT, 84123

Company Profile

n/a

Additional Details

Field Value
DUNS: 078508745
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 3


  1. SBIR Phase II: A Platform for Anthelmintic Drug Discovery using Genome-modified C. elegans

    Amount: $750,000.00

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is the development of a platform for the discovery of new anthelmintic (anti-parasite) drugs. ...

    SBIR Phase II 2015 National Science Foundation
  2. SBIR Phase I: A Platform for Anthelmintic Drug Discovery using DAF-12 as a Novel Target

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project creates a drug-screening platform for discovery of new antiparasitic drugs. Resistance to current drug treatments is on the rise. New ant ...

    SBIR Phase I 2013 National Science Foundation
  3. SBIR Phase I: Biosensors to Detect and Characterize Genotoxins

    Amount: $149,930.00

    This Small Business Innovation Research Phase I project creates GeniStress Responder. GeniStress Responder is part of EkaTox, a family of toxicology diagnostics harnessing the power of comparative gen ...

    SBIR Phase I 2012 National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government